Effects on Oxygen‐barrier Properties of Pretreating Paperboard with a Starch–Poly(Vinyl Alcohol) Blend before Polyethylene Extrusion

Polyethylene (PE) extrusion coating was performed on paperboard pre‐coated with water‐borne barrier coatings based on starch–poly(vinyl) (PVOH)–plasticizer blends in order to investigate that how the addition of a plasticizer to the pre‐coating affects the oxygen‐barrier properties of the board after PE extrusion coating. The plasticizers used were glycerol, polyethylene glycol (PEG) and citric acid (CA). Photomicrographs showed that the barrier coating layers were rather smooth, but defects were observed in the starch–PVOH layers when a plasticizer was added. Starch–PVOH layers had oxygen‐barrier properties similar to those of pure PVOH without plasticizers. When a sufficient number of layers (four layers) were applied to cover defects, the starch–PVOH layers containing CA showed oxygen transmission rate (OTR) values similar to those of starch–PVOH layers without plasticizer. The adhesion of PE to pre‐coated paperboard decreased when a plasticizer was added to the pre‐coating recipes. PE extrusion coating resulted in a reduction in the OTR in the case of pre‐coating formulations containing plasticizers. A lower OTR after polyethylene extrusion was observed with PEG as plasticizer than with CA as plasticizer. This could be explained by the increase in brittleness due to cross‐linking under the high temperature load during the extrusion process. Dynamic mechanical analysis of the films showed a substantial increase in storage modulus between 100°C and 200°C for CA‐containing starch–PVOH films. The contact angle of diiodomethane on the pre‐coating layer decreased when a plasticizer was added to the coating recipe indicating an increase in wetting of the PE melt. Addition of PEG to the pre‐coating led to a greater wetting than the addition of CA, and this may have sealed some defects in the pre‐coating leading to lower OTR values.     

A Poly(Propyleneimine) Dendrimer‐Based Polyplex‐System for Single‐Chain Antibody‐Mediated Targeted Delivery and Cellular Uptake of SiRNA

Therapeutics based on small interfering RNAs (siRNAs) offer a great potential to treat so far incurable diseases or metastatic cancer. However, the broad application of siRNAs using various nonviral carrier systems is hampered by unspecific toxic side effects, poor pharmacokinetics due to unwanted delivery of siRNA‐loaded nanoparticles into nontarget organs, or rapid renal excretion. In order to overcome these obstacles, several targeting strategies using chemically linked antibodies and ligands have emerged. This study reports a new modular polyplex carrier system for targeted delivery of siRNA, which is based on transfection‐disabled maltose‐modified poly(propyleneimine)‐dendrimers (mal‐PPI) bioconjugated to single chain fragment variables (scFvs). To achieve targeted delivery into tumor cells expressing the epidermal growth factor receptor variant III (EGFRvIII), monobiotinylated anti‐EGFRvIII scFv fused to a Propionibacterium shermanii transcarboxylase‐derived biotinylation acceptor (P‐BAP) is bioconjugated to mal‐PPI through a novel coupling strategy solely based on biotin–neutravidin bridging. In contrast to polyplexes containing an unspecific control scFv‐P‐BAP, the generated EGFRvIII‐specific polyplexes are able to exclusively deliver siRNA to tumor cells and tumors by receptor‐mediated endocytosis. These results suggest that receptor‐mediated uptake of otherwise noninternalized mal‐PPI‐based polyplexes is a promising avenue to improve siRNA therapy of cancer, and introduce a novel strategy for modular bioconjugation of protein ligands to nanoparticles.     

Desktop‐Stereolithography 3D‐Printing of a Poly(dimethylsiloxane)‐Based Material with Sylgard‐184 Properties

The advantageous physiochemical properties of poly(dimethylsiloxane) (PDMS) have made it an extremely useful material for prototyping in various technological, scientific, and clinical areas. However, PDMS molding is a manual procedure and requires tedious assembly steps, especially for 3D designs, thereby limiting its access and usability. On the other hand, automated digital manufacturing processes such as stereolithography (SL) enable true 3D design and fabrication. Here the formulation, characterization, and SL application of a 3D‐printable PDMS resin (3DP‐PDMS) based on commercially available PDMS‐methacrylate macromers, a high‐efficiency photoinitiator and a high‐absorbance photosensitizer, is reported. Using a desktop SL‐printer, optically transparent submillimeter structures and microfluidic channels are demonstrated. An optimized blend of PDMS‐methacrylate macromers is also used to SL‐print structures with mechanical properties similar to conventional thermally cured PDMS (Sylgard‐184). Furthermore, it is shown that SL‐printed 3DP‐PDMS substrates can be rendered suitable for mammalian cell culture. The 3DP‐PDMS resin enables assembly‐free, automated, digital manufacturing of PDMS, which should facilitate the prototyping of devices for microfluidics, organ‐on‐chip platforms, soft robotics, flexible electronics, and sensors, among others.     

A Self‐Organized Poly(vinylpyrrolidone)‐Based Cathode Interlayer in Inverted Fullerene‐Free Organic Solar Cells

Herein, poly(vinylpyrrolidone) (PVP) is used as the cathode interlayer (CIL) through the self‐organization method in inverted organic solar cells (OSCs). By coating a solution of PVP and active layer materials onto a glass/indium tin oxide (ITO) substrate, the PVP can segregate to the near ITO side due to its high surface energy and strong intermolecular interaction with the ITO electrode. The power conversion efficiency (PCE) of the obtained OSC device reaches 13.3%, much higher than that of the control device with a PCE of only 10.1%. The improvement results from the increased exciton dissociation efficiency and the depressed trap‐assisted recombination, which can be attributed to the reduced work function of the cathode by the self‐organized PVP. Additionally, the molecular weight of the PVP has almost no influence on the device performance, and the PVP‐modified device presents superior stability. This method can also be applied in other highly efficient fullerene‐free OSCs, and with a fine selection of the active layer, a high PCE of 14.0% is obtained. Overall, this work demonstrates the great potential of the PVP‐based CIL in inverted OSCs fabricated via the self‐organization method.     

Poly(N‐phenylglycine)‐Based Nanoparticles as Highly Effective and Targeted Near‐Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma

Malignant melanoma is a highly aggressive tumor resistant to chemotherapy. Therefore, the development of new highly effective therapeutic agents for the treatment of malignant melanoma is highly desirable. In this study, a new class of polymeric photothermal agents based on poly(N‐phenylglycine) (PNPG) suitable for use in near‐infrared (NIR) phototherapy of malignant melanoma is designed and developed. PNPG is obtained via polymerization of N‐phenylglycine (NPG). Carboxylate functionality of NPG allows building multifunctional systems using covalent bonding. This approach avoids complicated issues typically associated with preparation of polymeric photothermal agents. Moreover, PNPG skeleton exhibits pH‐responsive NIR absorption and an ability to generate reactive oxygen species, which makes its derivatives attractive photothermal therapy (PTT)/photodynamic therapy (PDT) dual‐modal agents with pH‐responsive features. PNPG is modified using hyaluronic acid (HA) and polyethylene glycol diamine (PEG‐diamine) acting as the coupling agent. The resultant HA‐modified PNPG (PNPG‐PEG‐HA) shows negligible cytotoxicity and effectively targets CD44‐overexpressing cancer cells. Furthermore, the results of in vitro and in vivo experiments reveal that PNPG‐PEG‐HA selectively kills B16 cells and suppresses malignant melanoma tumor growth upon exposure to NIR light (808 nm), indicating that PNPG‐PEG‐HA can serve as a very promising nanoplatform for targeted dual‐modality PTT/PDT of melanoma.